ALGRE — Algreen SA Income Statement
0.000.00%
Last trade - 00:00
- €0.00m
- €5.82m
- €6.92m
2018 December 31st | 2019 December 31st | 2020 December 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.952 | 1.37 | 2.11 | 5.98 | 6.92 |
Cost of Revenue | |||||
Gross Profit | 0.338 | 0.38 | 0.698 | -0.538 | 0.077 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.36 | 3.07 | 3.62 | 8.54 | 8.32 |
Operating Profit | -1.4 | -1.7 | -1.52 | -2.56 | -1.41 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.42 | -1.79 | -1.6 | -2.8 | -11.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.42 | -1.79 | -1.6 | -2.83 | -11.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.42 | -1.79 | -1.6 | -2.83 | -11 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.42 | -1.79 | -1.6 | -2.83 | -11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -14.5 | -16.3 | -14.5 | -3.75 | -17.1 |
Dividends per Share |